Synexus opens clinical research centre in Bochum, Germany

Synexus, a multinational company focused on the recruitment and running of clinical trials, has officially opened a new state-of-the-art clinical trial centre in Bochum, Germany. The clinic, which moved from a much smaller site in Bochum, started operations at the beginning of this month.

Located in the historic Kortum House, the 500m² clinic runs primary care clinical trials for major clinical research organisations (CROs) and pharmaceutical companies. It provides facilities for up to six professional investigators.

The opening, attended by clients and leading doctors, was performed by Christophe Berthoux, CEO of Synexus, who said: 'Germany is one of our foremost locations for running clinical trials with its excellent medical expertise, a history of running clinical trials and a large population. Europe continues to be a favoured region for our clients in the running of their global clinical trials and we are planning to further develop our business in Germany.'

Synexus, a world leader in recruiting patients for clinical trials at its dedicated research centres across Europe and Africa, has four major and three smaller research clinics in Germany.

Christoph Dietrich, Managing Director of Synexus Germany, said: 'This is a further step in our plan to update and expand our very successful network of clinics across Germany by providing modern clinics which benefit both our patients and our clients in pharma. Our success in bringing clinical trials to Germany is dependent on our ability to deliver patients and quality data. We have now put in place a sophisticated patient engagement programme which improves the patient experience and it is these added-value extras which really pay dividends in terms of client success.'

The new clinic, which will be managed by Annette Kuehlenborg, is well placed for easy patient access as it is close to the main station and has parking facilities in the immediate vicinity.

All of Synexus’ 24 clinics across Europe and Africa focus on undertaking clinical trials in the therapy areas where the company can provide most value – cardiovascular, metabolic (diabetes and obesity), musculo skeletal, respiratory and CNS (dementia and pain).